Flindr Therapeutics

Flindr – first in class small molecule targeted therapeutics

Flindr Therapeutics is a biotech company in Oss, Netherlands, founded in 2020. It has raised $21.4M across 1 round, most recently a $21.4M Series A in April 2024.

Headquarters
Oss
Employees
1–10
Founded
2020
Total Funding
$21.4M
Last Round
$21.4M Series AApr 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Flindr Therapeutics develops a pipeline of first-in-class small molecule inhibitors for the precision treatment of cancer. Its ImmunoGram Drug Discovery Engine combines target identification and validation, clinical bio-informatics, and druggability evaluation. Its RNF31 inhibitors block NF-kB activation and induce RIPK1-induced cell death in preclinical hematological and solid cancer models.

Summary

It lists 1–10 employees. It has raised $21.4M in total across 1 round, most recently a $21.4M Series A round in Apr 2024. Investors include V-Bio Ventures and Johnson & Johnson Innovation.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AApr 2024
$21.4M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Flindr Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/flindr-therapeutics"><img src="https://indexed.vc/api/badge/company/flindr-therapeutics" alt="Flindr Therapeutics on Indexed.vc" width="260" height="76" /></a>